Hytest Appoints New CCO and General Manager of Hytest China

Published: 05.07.2023
05 Jul, 2023
Hytest Webinar: Clinical Applications of Procalcitonin (PCT) and Challenges in Measurement Standardization

Procalcitonin (PCT) is an established biomarker, which is used to guide antibiotic treatment in septic patient. As an invaluable indicator, it shows high sensitivity and specificity for bacterial infection. Given the utility of PCT in clinical setting, variability in results from different commercial assays have been observed. In this webinar, participants will have the opportunity to review the clinical application of PCT, technology used for PCT measurements and also the challenges in terms of the standardization effort.

Read more
20 Jun, 2023
Meet us at AACC Annual Scientific Meeting & Clinical Lab Expo in July

#teamhytest is looking forward to meeting our customers at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim!

Read more
13 Jun, 2023
Hut Coats Appointed as General Manager of Hytest North America

We are happy to introduce General Manager of HyTest North America Hut Coats. With Hut in our team, we’re able to be closer to our customers in North America and provide even better service.

Read more
01 Jun, 2023
The Winner of the Fourth EFLM-HyTest Cardiac Marker

The EFLM Award Committee had a difficult task in selecting for the most remarkable scientific work among the submitted papers but in the end Rami Aalto, (University of Turku, Finland) was selected to receive the award.

Read more
17 May, 2023
Hytest Appoints Netta Keinänen as New CEO

We are pleased to announce that Netta Keinänen, a valued member of our leadership team, will be stepping into the role of CEO on June 5th, 2023. With her experience, leadership, and strategic vision, we are confident that Netta will continue to lead us to even greater success.  

Read more
27 Apr, 2023
New Troponin Product Available

We have launched a new troponin MAb Y302 recombinant monoclonal antibody, which is expressed in a mammalian cell line and contains full-size IgG sequence derived from rabbit B cells and epitope specificity for this MAb is 83 – 100 a.a.r. of human cardiac troponin I.

Read more
30 Mar, 2023
New Article: Fragmentation of Human Cardiac Troponin T After Acute Myocardial Infarction

A new article titled "Fragmentation of human cardiac troponin T after acute myocardial infarction" by our scientists was published in Clinica Chimica Acta journal.

Read more
30 Mar, 2023
New Product: Recombinant Thyroglobulin

We are launching a new product, recombinant thyroglobulin, Cat # 8RTG4.

Read more
27 Jan, 2023
New Antibodies for Cardiac Troponin I

Troponin I and T are the main biomarkers and gold standards for diagnostics of acute myocardial infarction (AMI). Recently high- sensitivity cTn (hs-cTn) assays, the detection limit of which is pg/ml (ng/l) rather than ng/ml, have made it possible to identify any myocardial injury, including those AMI patients, within 1 to 3 hours. This represents a potential 3-hour time saving to ensure more rapid patient management.

Read more
25 Jan, 2023
New Antibodies for NT-proBNP

HF is a severe clinical and public health problem that is characterized by an increasing prevalence and economic cost. NT-proBNP, a derivative of pro-B-type natriuretic peptide (proBNP), is an established biomarker for heart failure (HF) diagnostics.

Read more
30 Nov, 2022
Meet our Team at Medlab Middle East 2023

We will be attending Medlab Middle East 2023 in the beginning of February.

Read more
30 Nov, 2022
Are you Prepared for the Busy Flu Season?

Seasonal flu is an acute respiratory infection caused by influenza viruses, including influenza A and influenza B. The typical symptoms include headaches, running nose, cough and muscle pain. The infection of other respiratory viruses, such as respiratory syncytial virus (RSV), can also present flu-like symptoms.

Read more
31 Oct, 2022
New Product: New Clones for Cardiac Troponin I

HyTest offers 5 new antibodies specific for cTnI. The antibodies are specific to epitopes 22-40 (Y306 and Y503), 83-100 (Y101), 161-178 (Y501), and 174-191 (Y502).

Read more
30 Sep, 2022
Troponin in the Real World - Cardiac Marker Dialogues Meeting

We are sponsoring the Cardiac Marker Dialogues meeting.

Read more
27 Sep, 2022
Meet #teamhytest at Medica 2022

We will be attending Medica trade show 2022.

Medica 2022, the World Medicine Forum will take place 14-17 November 2022 in Düsseldorf, Germany.

Read more
22 Sep, 2022
Call for Nominations: EFLM Cardiac Marker Award - Sponsored by HyTest

The Award is given to the best published paper, as judged by an independent panel of experts, which demonstrates a remarkable scientific work in the field of cardiovascular diseases.
The Award, consisting of a certificate and a sum of 5,000 Euro,
will be presented to the first author, who is responsible for division among co-authors, at the 25th IFCC-EFLM EuroMedLab Congress to be held in Rome from 21 to 25 May 2023.

Read more
18 Aug, 2022
New Product: Dimeric recombinant human PAPP-A

Pregnancy-associated plasma protein-A (PAPP-A) is a metalloprotease that belongs to the metzincin superfamily of zinc peptidases. Its main substrate is the insulin-like growth factor binding protein-4 (IGFBP-4). This cleavage causes the release of bound IGF, which plays an important role in promoting cell differentiation and proliferation. PAPP-A was first identified in the serum of pregnant women, hence its name. It was later shown to be expressed in multiple tissues.

Read more
10 Jun, 2022
Meet HyTest Team at AACC 2022

We will be participating the 2022 AACC Annual Meeting & Clinical Lab Expo. The exhibition will be on July 26 - 28 in Chicago.

Read more
10 May, 2022
New Product: Recombinant Human CRP Antigen

Human C-reactive protein (CRP) is one of the so-called acute phase proteins. CRP is produced in liver and its concentration in blood increases rapidly after a single systemic stimulus and the serum concentrations rise quickly.

Read more

Do you need samples?

We are happy to make you an offer